Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study to Investigate the Potential for AZD5672 to Affect the Electrical Conduction Pathways in the Heart

This study has been completed.
Quintiles, Inc.
Information provided by:
AstraZeneca Identifier:
First received: April 23, 2009
Last updated: July 15, 2009
Last verified: July 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2009
  Estimated Primary Completion Date: No date given